Ultrafem(UFEM) great potential-new feminine protection Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ultrafem(UFEM) great potential-new feminine protection

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Loeb who wrote (270)	5/18/1998 5:34:00 PM
From: Larry Loeb	of 272

It's almost over: Company Press Release SOURCE: Houlihan Lokey Howard & Zukin Capital Houlihan Lokey Howard & Zukin Capital Hired for Immediate Sale of Ultrafem NEW YORK, May 15 /PRNewswire/ -- The Official Creditors Committee of Ultrafem, Inc. (OTC Bulletin Board: UFEMQ - news) today announced that it has retained the investment banking firm of Houlihan Lokey Howard & Zukin Capital to assist the Company in locating a buyer and closing a prompt sale. The Company is supporting the sale process, and has indicated it will fully cooperate with Houlihan Lokey. Houlihan Lokey is targeting a sale ''free and clear'' within the next 30 to 60 days. Ultrafem is a women's health care company. The Company's business strategy is to develop, design and manufacture over-the-counter women's health care products based on its patented and proprietary SoftCup(R) technology. The Company currently sells the INSTEAD(R) feminine protection product and distributes it on a regional basis in 25% of the Western United States in supermarkets, drugstores and mass merchandising chains and nationally in selected drugstore chains. The Company believes there are substantial opportunities for utilizing the SoftCup(R) technology to develop future products in contraception and other vaginal applications. Please contact either Mike Stewart or Tanja Aalto of Houlihan Lokey Howard & Zukin Capital at (212) 582-5000 with any inquiries. The statements contained in this release which are not historical facts are forward-looking statements that involve risk and uncertainties. Such risks include, but are not limited to, the bankruptcy process and various factors effecting the business. Houlihan Lokey wishes to caution the reader that any forward-looking statements are only predictions; actual events or results may differ materially as a result of risks. SOURCE: Houlihan Lokey Howard & Zukin Capital

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next